In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Overview
Darzalex Faspro is approved by the U.S. Food and Drug Administration (FDA) for the treatment of newly diagnosed light chain (AL) amyloidosis in adults. This approval is under the FDA’s accelerated approval…
Join